• GQG Partners shares in focus after August 2026 FUM update

    Broker looking at the share price.

    The GQG Partners Inc (ASX: GQG) share price is in focus today after the fund manager reported total funds under management (FUM) of US$149.2 billion as at 31 August 2026, down from US$156.4 billion a month earlier. Over the month, net outflows totalled US$4.3 billion and the impact of investment performance was negative US$2.9 billion.

    What did GQG Partners report?

    • Total FUM at 31 August 2026: US$149.2 billion
    • August 2026 net outflows: US$4.3 billion
    • August 2026 investment performance: –US$2.9 billion
    • Year-to-date (YTD) net outflows: US$23.9 billion
    • YTD investment performance: +US$9.2 billion

    What else do investors need to know?

    GQG’s FUM declined on both a monthly and year-to-date basis, mainly driven by net outflows across all investment strategies. The international strategy was the largest segment, finishing August with US$68.6 billion in FUM after a combination of net outflows and negative investment returns.

    While investment performance for August was negative, the year-to-date figure remains positive, suggesting that returns have added to FUM in the longer term. Notably, GQG Private Capital Solutions activity is not included in the reported figures.

    What’s next for GQG Partners?

    Investors can expect the next FUM update on 12 October 2026, with subsequent monthly updates following. Management will be looking to address ongoing net outflows and stabilise assets under management across their international, emerging markets, global, and US strategies.

    GQG says these results reflect dynamic client flows and market conditions, and the group continues to prioritise long-term performance and client alignment.

    GQG Partners share price snapshot

    Over the past year, the GQG Partners shares have declined 29%, trailing the S&P/ASX 200 Index (ASX: XJO), which is flat over the same period.

    View Original Announcement

    The post GQG Partners shares in focus after August 2026 FUM update appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Gqg Partners right now?

    Before you buy Gqg Partners shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Gqg Partners wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Gqg Partners. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • 3 ASX shares with dividend yields of between 6% and 11%

    Piles of increasing coins on Australian $100 notes.

    Companies that pay high dividend yields are great, but it’s also important to consider whether those dividends are sustainable.

    Two of the companies I’m looking at today are infrastructure or infrastructure-like companies, typified by long contracts that provide income certainty.

    That gives investors some certainty that the business, if managed well, can make long-term forecasts for its income and liabilities and, hopefully, keep its dividend payments steady.

    Let’s look at the companies I’ve selected that currently pay solid dividends.

    Aurizon Ltd (ASX: AZJ)

    Rail operator Aurizon is currently paying a 6.18% dividend yield, 90% franked.

    The company’s shares are also up about 18% over the past year, despite a recent dip after the announcement of its results.

    After releasing its results, Aurizon announced a new $250 million share buyback, following a buyback completed during FY26.

    The company grew EBITDA last financial year by 9% to $1.72 billion, and paid out 90% of its net profit as dividends.

    Aurizon is expecting to pay 23 cents to 24 cents per share in dividends this year, which would be a 6.4% dividend yield at the current share price.

    Atlas Arteria Ltd (ASX: ALX)

    This toll road operator faced a takeover bid during the year, which contributed to the company posting a net loss. However, apart from that, the company described its performance as stable.

    Brokers expect Atlas to maintain its distribution at 40 cents per share, in line with current-year guidance, which yields 8.7%.

    The company itself said it will no longer provide guidance for dividend payments beyond a one year period.

    The company added:

    Going forward, we will continue to focus on optimising free cash flow to drive strong distributions. Distributions will align with free cash flow by maintaining the distribution policy to pay 90–110% of free cash flow on a full-year basis.

    Regal Partners Ltd (ASX: RPL)

    Financial services company Regal Partners is currently paying a very healthy dividend yield of 11.1%, after more than doubling its net profit over the past financial year.

    The company’s Managing Director Brendan O’Connor said their balance sheet was “exceptionally strong”, with $290 million in capital on hand after the payment of the dividend, along with excess franking credits.

    Mr O’Connor said at the time:

    I also note the investment landscape continues to evolve rapidly, shaped by an artificial intelligence fuelled capital expenditure boom, shifting geopolitical dynamics, the proposed removal of the capital gains tax discount regime, and persistent inflation. Against this backdrop, we are seeing growing demand for income-oriented products and look forward to launching our Multi-Strategy Income Fund in September. More broadly, we believe our suite of alternative strategies is very well placed to meet client needs in this environment.

    The post 3 ASX shares with dividend yields of between 6% and 11% appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Aurizon right now?

    Before you buy Aurizon shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Aurizon wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Higher or lower: Where are CSL shares going next?

    ASX share investor sitting with a laptop on a desk, pondering something.

    After a period of seemingly relentless declines, CSL Ltd (ASX: CSL) shares have finally found some love in recent weeks.

    In fact, the biotech giant’s shares have been on an absolute tear, rising almost 90% since hitting a multi-year low of $90.00 in June.

    Those gains are not too surprising given the dirt cheap valuation at the time, but what about the future? 

    Do analysts think CSL shares are going higher or lower from here? Let’s dig deeper into things and find out.

    Where next for CSL shares?

    Before looking at where the company’s shares could be heading, let’s have a quick reminder of why they have rallied.

    As I mentioned at the top, the CSL share price was well and truly down in the doldrums at just $90.00.

    This was a level that investors hadn’t seen in over a decade. Not even during the COVID market crash did its shares get anywhere near that level.

    The market was essentially valuing CSL like it was broken and without a fix. 

    However, a much better than expected FY 2026 result and improving confidence in its outlook helped change the narrative and investors came flooding back.

    Which is why CSL shares are suddenly trading at $169.50 today.

    Though, it is worth noting that this is still well short of its record high, so we are only in the early stages of a full recovery.

    What are brokers predicting?

    The good news is that a number of top brokers still see value in the company’s shares despite its strong gains over the past three months.

    For example, the team at UBS has a buy rating and $181.00 price target on them. This implies potential upside of around 7% over the next 12 months.

    Elsewhere, Morgan Stanley has an overweight rating and slightly higher price target of $182.00.

    And over at Morgans, its analysts have a buy rating and $187.71 price target, which offers potential upside of approximately 11%. It said:

    The FY26 result was broadly in line with expectations, with revenue of US$15.8bn (+3% vs guidance) and underlying NPATA of US$3.1bn. Importantly, underlying Ig demand remains strong, Seqirus delivered seasonal influenza growth despite lower US immunisation rates and transformation savings reached US$176m ahead of target, although Vifor continues to face challenges. 

    While FY27 targets flat top line growth, as Vifor remains a significant drag, the earnings trajectory is becoming increasingly skewed towards recovery, supported by stabilising plasma economics, cost-outs and improved commercial execution. We make modest changes to FY27-28 estimates and increase our blended DCF, PE and EV/EBITDA-based target price to A$187.71 on a multiple roll forward. BUY.

    It is worth noting that not everyone is positive. Macquarie has a neutral rating and $133.00 price target and Bell Potter is sitting at hold with a $150.00 price target.

    The post Higher or lower: Where are CSL shares going next? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in CSL right now?

    Before you buy CSL shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and CSL wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor James Mickleboro has positions in CSL. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Macquarie Group. The Motley Fool Australia has recommended CSL and Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • What Can The Trends At Celsius Holdings (NASDAQ:CELH) Tell Us About Their Returns?

  • Analysts Just Published A Bright New Outlook For The Goldman Sachs Group, Inc.’s (NYSE:GS)

  • Energy Fuels Strengthens Balance Sheet by Eliminating Debt and Growing Uranium Inventories

  • Exclusive: EU in talks with Moderna, BioNtech, CureVac to secure possible COVID vaccines – sources